Does the media prefer BHST or MED?

In the previous week, BioHarvest Sciences had 17 more articles in the media than Medifast. MarketBeat recorded 20 mentions for BioHarvest Sciences and 3 mentions for Medifast. Medifast's average media sentiment score of 0.27 beat BioHarvest Sciences' score of -0.05 indicating that Medifast is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Medifast 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer BHST or FTLF?

In the previous week, BioHarvest Sciences had 14 more articles in the media than FitLife Brands. MarketBeat recorded 20 mentions for BioHarvest Sciences and 6 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.89 beat BioHarvest Sciences' score of -0.05 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral FitLife Brands 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SKIN or BHST?

In the previous week, BioHarvest Sciences had 7 more articles in the media than Beauty Health. MarketBeat recorded 20 mentions for BioHarvest Sciences and 13 mentions for Beauty Health. Beauty Health's average media sentiment score of 0.78 beat BioHarvest Sciences' score of -0.05 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 7 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioHarvest Sciences 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer BHST or LFVN?

In the previous week, BioHarvest Sciences had 17 more articles in the media than Lifevantage. MarketBeat recorded 20 mentions for BioHarvest Sciences and 3 mentions for Lifevantage. Lifevantage's average media sentiment score of 0.63 beat BioHarvest Sciences' score of -0.05 indicating that Lifevantage is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Lifevantage 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer SLSN or BHST?

BioHarvest Sciences has a consensus target price of $6.50, suggesting a potential upside of 214.01%. Given BioHarvest Sciences' stronger consensus rating and higher probable upside, analysts clearly believe BioHarvest Sciences is more favorable than Solesence. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solesence 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioHarvest Sciences 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media favor SLSN or BHST?

In the previous week, BioHarvest Sciences had 17 more articles in the media than Solesence. MarketBeat recorded 20 mentions for BioHarvest Sciences and 3 mentions for Solesence. Solesence's average media sentiment score of 0.63 beat BioHarvest Sciences' score of -0.05 indicating that Solesence is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solesence 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioHarvest Sciences 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

BioHarvest Sciences (BHST) Competitors

$2.07 0.00 (0.00%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$2.09 +0.02 (+0.97%)

As of 08/14/2026 07:34 PM Eastern

Compare

BHST vs. MED, FTLF, SKIN, LFVN, and SLSN

Should you buy BioHarvest Sciences stock or one of its competitors? BioHarvest Sciences's main competitors and comparable companies include Medifast (MED), FitLife Brands (FTLF), Beauty Health (SKIN), Lifevantage (LFVN), and Solesence (SLSN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does BioHarvest Sciences compare to Medifast?

BioHarvest Sciences (NASDAQ:BHST) and Medifast (NYSE:MED) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

BioHarvest Sciences currently has a consensus price target of $6.50, suggesting a potential upside of 214.01%. Medifast has a consensus price target of $12.00, suggesting a potential upside of 4.90%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, equities analysts clearly believe BioHarvest Sciences is more favorable than Medifast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Medifast	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

95.5% of Medifast shares are held by institutional investors. 3.7% of Medifast shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Medifast has a net margin of -8.08% compared to BioHarvest Sciences' net margin of -31.21%. Medifast's return on equity of -6.69% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-31.21%	-58.30%	-25.60%
Medifast	-8.08%	-6.69%	-5.25%

BioHarvest Sciences has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, Medifast has a beta of 0.65, meaning that its share price is 35% less volatile than the broader market.

In the previous week, BioHarvest Sciences had 17 more articles in the media than Medifast. MarketBeat recorded 20 mentions for BioHarvest Sciences and 3 mentions for Medifast. Medifast's average media sentiment score of 0.27 beat BioHarvest Sciences' score of -0.05 indicating that Medifast is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioHarvest Sciences	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Medifast	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

BioHarvest Sciences has higher earnings, but lower revenue than Medifast. Medifast is trading at a lower price-to-earnings ratio than BioHarvest Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioHarvest Sciences	$34.51M	1.18	-$11.14M	-$0.52	N/A
Medifast	$385.79M	0.33	-$18.67M	-$2.33	N/A

Summary

BioHarvest Sciences beats Medifast on 9 of the 16 factors compared between the two stocks.

How does BioHarvest Sciences compare to FitLife Brands?

BioHarvest Sciences (NASDAQ:BHST) and FitLife Brands (NASDAQ:FTLF) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

BioHarvest Sciences has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market. Comparatively, FitLife Brands has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market.

In the previous week, BioHarvest Sciences had 14 more articles in the media than FitLife Brands. MarketBeat recorded 20 mentions for BioHarvest Sciences and 6 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.89 beat BioHarvest Sciences' score of -0.05 indicating that FitLife Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioHarvest Sciences	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
FitLife Brands	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

2.3% of FitLife Brands shares are held by institutional investors. 61.7% of FitLife Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

BioHarvest Sciences presently has a consensus target price of $6.50, suggesting a potential upside of 214.01%. FitLife Brands has a consensus target price of $21.50, suggesting a potential upside of 99.07%. Given BioHarvest Sciences' higher probable upside, equities research analysts plainly believe BioHarvest Sciences is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
FitLife Brands	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

FitLife Brands has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioHarvest Sciences	$34.51M	1.18	-$11.14M	-$0.52	N/A
FitLife Brands	$81.46M	1.24	$6.33M	$0.60	18.00

FitLife Brands has a net margin of 6.15% compared to BioHarvest Sciences' net margin of -31.21%. FitLife Brands' return on equity of 18.49% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-31.21%	-58.30%	-25.60%
FitLife Brands	6.15%	18.49%	7.55%

Summary

FitLife Brands beats BioHarvest Sciences on 12 of the 15 factors compared between the two stocks.

How does BioHarvest Sciences compare to Beauty Health?

Beauty Health (NASDAQ:SKIN) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

Beauty Health has a net margin of -9.79% compared to BioHarvest Sciences' net margin of -31.21%. Beauty Health's return on equity of -47.83% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-9.79%	-47.83%	-5.79%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

93.3% of Beauty Health shares are held by institutional investors. 40.3% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Beauty Health presently has a consensus price target of $1.38, suggesting a potential upside of 106.15%. BioHarvest Sciences has a consensus price target of $6.50, suggesting a potential upside of 214.01%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, analysts clearly believe BioHarvest Sciences is more favorable than Beauty Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, BioHarvest Sciences had 7 more articles in the media than Beauty Health. MarketBeat recorded 20 mentions for BioHarvest Sciences and 13 mentions for Beauty Health. Beauty Health's average media sentiment score of 0.78 beat BioHarvest Sciences' score of -0.05 indicating that Beauty Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioHarvest Sciences	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Beauty Health has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$300.80M	0.29	-$9.52M	-$0.22	N/A
BioHarvest Sciences	$34.51M	1.18	-$11.14M	-$0.52	N/A

Beauty Health has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, BioHarvest Sciences has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market.

Summary

Beauty Health beats BioHarvest Sciences on 11 of the 16 factors compared between the two stocks.

How does BioHarvest Sciences compare to Lifevantage?

BioHarvest Sciences (NASDAQ:BHST) and Lifevantage (NASDAQ:LFVN) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

BioHarvest Sciences has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market. Comparatively, Lifevantage has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market.

In the previous week, BioHarvest Sciences had 17 more articles in the media than Lifevantage. MarketBeat recorded 20 mentions for BioHarvest Sciences and 3 mentions for Lifevantage. Lifevantage's average media sentiment score of 0.63 beat BioHarvest Sciences' score of -0.05 indicating that Lifevantage is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioHarvest Sciences	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lifevantage	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

35.3% of Lifevantage shares are held by institutional investors. 22.0% of Lifevantage shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Lifevantage has a net margin of 2.94% compared to BioHarvest Sciences' net margin of -31.21%. Lifevantage's return on equity of 23.89% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-31.21%	-58.30%	-25.60%
Lifevantage	2.94%	23.89%	12.47%

BioHarvest Sciences presently has a consensus price target of $6.50, suggesting a potential upside of 214.01%. Lifevantage has a consensus price target of $5.00, suggesting a potential downside of 23.90%. Given BioHarvest Sciences' stronger consensus rating and higher probable upside, research analysts plainly believe BioHarvest Sciences is more favorable than Lifevantage.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Lifevantage	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Lifevantage has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioHarvest Sciences	$34.51M	1.18	-$11.14M	-$0.52	N/A
Lifevantage	$228.53M	0.36	$9.81M	$0.45	14.60

Summary

Lifevantage beats BioHarvest Sciences on 10 of the 16 factors compared between the two stocks.

How does BioHarvest Sciences compare to Solesence?

Solesence (NASDAQ:SLSN) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

In the previous week, BioHarvest Sciences had 17 more articles in the media than Solesence. MarketBeat recorded 20 mentions for BioHarvest Sciences and 3 mentions for Solesence. Solesence's average media sentiment score of 0.63 beat BioHarvest Sciences' score of -0.05 indicating that Solesence is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solesence	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioHarvest Sciences	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

70.2% of Solesence shares are owned by institutional investors. 4.8% of Solesence shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Solesence has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Solesence, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solesence	$62.06M	1.16	$1.79M	$0.01	102.00
BioHarvest Sciences	$34.51M	1.18	-$11.14M	-$0.52	N/A

BioHarvest Sciences has a consensus target price of $6.50, suggesting a potential upside of 214.01%. Given BioHarvest Sciences' stronger consensus rating and higher probable upside, analysts clearly believe BioHarvest Sciences is more favorable than Solesence.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solesence	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Solesence has a net margin of 1.56% compared to BioHarvest Sciences' net margin of -31.21%. Solesence's return on equity of 5.39% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solesence	1.56%	5.39%	1.78%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

Solesence has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, BioHarvest Sciences has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

Summary

Solesence beats BioHarvest Sciences on 11 of the 16 factors compared between the two stocks.

Get BioHarvest Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BHST vs. The Competition

Export

Metric	BioHarvest Sciences	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$40.61M	$22.60B	$16.13B	$13.10B
Dividend Yield	N/A	4.29%	3.20%	10.45%
P/E Ratio	-3.98	15.46	13.30	25.28
Price / Sales	1.18	12.56	262,280.37	91.31
Price / Cash	N/A	29.73	57.60	50.90
Price / Book	2.05	2.80	5.06	6.24
Net Income	-$11.14M	$1.08B	$831.83M	$347.60M
7 Day Performance	-19.14%	-0.93%	0.59%	1.06%
1 Month Performance	-27.37%	-0.42%	1.48%	0.81%
1 Year Performance	-77.79%	-13.80%	13.68%	20.90%

BioHarvest Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BHST BioHarvest Sciences	2.973 of 5 stars	$2.07 flat	$6.50 +214.0%	-77.5%	$40.61M	$34.51M	N/A	N/A	Trending News Earnings Report Analyst Forecast Analyst Revision
MED Medifast	1.3956 of 5 stars	$9.83 -0.9%	$12.00 +22.1%	-12.3%	$109.30M	$385.79M	N/A	870	Analyst Downgrade
FTLF FitLife Brands	3.6923 of 5 stars	$9.91 +0.2%	$21.50 +117.0%	-33.1%	$93.07M	$81.46M	16.41	20	News Coverage Earnings Report
SKIN Beauty Health	3.2058 of 5 stars	$0.69 +1.4%	$1.53 +122.5%	-69.3%	$88.84M	$300.80M	N/A	1,030	Analyst Forecast
LFVN Lifevantage	1.7951 of 5 stars	$6.43 +2.2%	$5.00 -22.2%	-52.0%	$81.12M	$228.53M	14.29	260	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BHST) was last updated on 8/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioHarvest Sciences (BHST) Competitors

BHST vs. MED, FTLF, SKIN, LFVN, and SLSN

How does BioHarvest Sciences compare to Medifast?

Summary

How does BioHarvest Sciences compare to FitLife Brands?

Summary

How does BioHarvest Sciences compare to Beauty Health?

Summary

How does BioHarvest Sciences compare to Lifevantage?

Summary

How does BioHarvest Sciences compare to Solesence?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHST vs. The Competition

BioHarvest Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BioHarvest Sciences (BHST) Competitors

BHST vs. MED, FTLF, SKIN, LFVN, and SLSN

How does BioHarvest Sciences compare to Medifast?

Do analysts rate BHST or MED?

Do insiders & institutionals hold more shares of BHST or MED?

Is BHST or MED more profitable?

Which has more risk and volatility, BHST or MED?

Does the media prefer BHST or MED?

Which has preferable earnings & valuation, BHST or MED?

Summary

How does BioHarvest Sciences compare to FitLife Brands?

Which has more volatility and risk, BHST or FTLF?

Does the media prefer BHST or FTLF?

Do insiders and institutionals hold more shares of BHST or FTLF?

Do analysts rate BHST or FTLF?

Which has stronger valuation & earnings, BHST or FTLF?

Is BHST or FTLF more profitable?

Summary

How does BioHarvest Sciences compare to Beauty Health?

Is SKIN or BHST more profitable?

Do insiders and institutionals have more ownership in SKIN or BHST?

Do analysts prefer SKIN or BHST?

Does the media favor SKIN or BHST?

Which has stronger earnings & valuation, SKIN or BHST?

Which has more volatility & risk, SKIN or BHST?

Summary

How does BioHarvest Sciences compare to Lifevantage?

Which has more volatility & risk, BHST or LFVN?

Does the media prefer BHST or LFVN?

Do institutionals & insiders hold more shares of BHST or LFVN?

Is BHST or LFVN more profitable?

Do analysts rate BHST or LFVN?

Which has stronger valuation & earnings, BHST or LFVN?

Summary

How does BioHarvest Sciences compare to Solesence?

Does the media favor SLSN or BHST?

Do insiders & institutionals hold more shares of SLSN or BHST?

Which has better valuation and earnings, SLSN or BHST?

Do analysts prefer SLSN or BHST?

Is SLSN or BHST more profitable?

Which has more volatility and risk, SLSN or BHST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHST vs. The Competition

BioHarvest Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools